Accelerate Diagnostics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$573.64 | $591.94 | 8.08% | 1 | $218.97B |
| ROG | Roche Holding | Hold |
16
|
CHF222.30 | CHF307.83 | 22.58% | 9 | CHF179.41B |
| DHR | Danaher | Outperform |
10
|
$249.55 | $260.33 | 9.17% | 4 | $184.84B |
| SIE | Siemens | Outperform |
10
|
181.58€ | 178.14€ | 7.67% | 11 | 142.34€B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$233.58 | $284.47 | 18.80% | 8 | $67.51B |
| SHL | Siemens Healthineers | Buy |
8
|
51.88€ | 56.34€ | 15.65% | 9 | 57.89€B |
| ILMN | Illumina | Outperform |
16
|
$110.62 | $159.28 | 33.34% | 9 | $17.62B |
| HOLX | Hologic | Outperform |
8
|
$75.86 | $81.06 | 11.39% | 3 | $17.70B |
| DGX | Quest Diagnostics | Outperform |
10
|
$136.14 | $141.17 | 6.51% | 8 | $15.12B |
| BIM | bioMérieux | Outperform |
18
|
99.10€ | 105.55€ | 16.04% | 1 | 11.71€B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$42.94 | $0.00 | 16.44% | 3 | $9.53B |
| QDEL | Quidel Corp | Hold |
16
|
$42.68 | $121.00 | 17.15% | 6 | $2.85B |
| NEO | NeoGenomics | Outperform |
8
|
$15.13 | $20.09 | 25.58% | 9 | $1.95B |
| VCYT | Veracyte | Outperform |
11
|
$20.12 | $32.17 | 64.02% | 4 | $1.61B |
| A096530 | Seegene |
18
|
₩22.35k | ₩25.00k | 11.86% | 0 | ₩1.02T | |
| CRDF | Cardiff Oncology | Buy |
10
|
$3.20 | $8.37 | 165.63% | 1 | $154.70M |
| TTOO | T2 Biosystems | Hold |
6
|
$3.05 | $8.68 | -1.64% | 0 | $31.92M |
| BCART | Biocartis Group NV | - |
7
|
0.29€ | 1.10€ | -100.00% | 0 | 27.24€M |
| OPGN | OpGen |
2
|
$0.48 | $3.00 | -100.00% | 1 | $4.61M | |
| IDXG | Interpace Biosciences | - |
0
|
$1.06 | $11.00 | -100.00% | 0 | $4.54M |
| ROSG.Q | Rosetta Genomics | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |